Table 2. Results for each group.
| Efficacy | NAC group (N=15) | Adjuvant group (N=5) | Consolidation group (N=14) | Salvage group (N=5) |
|---|---|---|---|---|
| ORR (%) | 86.7 | – | – | 60.0 |
| Mean PFS (months) | 21.5 | 24.1 | 26.9 | 13.9 |
| Mean OS (months) | 22.8 | 24.2 | 28.1 | 17.1 |
| 2-year OS rates (%) | 66.0 | 80.0 | 92.9 | 0.0 |
NAC, neoadjuvant chemotherapy; ORR, objective response rate; PFS, progression-free survival; OS, overall survival.